SCHEMBL4515657

SCHEMBL4515657

Cc1c(NC2CC2)c(C(=O)O)cc(F)c1N1CCC(NC(=O)OC(C)(C)C)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 6/20 0.40
CTSK P43235 2/20 0.40
PIM1 P11309 1/20 0.39
PIM3 Q86V86 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
CKS1B P61024 1/20 0.38
SKP1 P63208 1/20 0.38
SKP2 Q13309 1/20 0.38
KDM4D Q6B0I6 3/20 0.38
SYK P43405 1/20 0.38
TRPV1 Q8NER1 2/20 0.37
EGFR P00533 1/20 0.37
TEC P42680 1/20 0.37
TXK P42681 1/20 0.37
BMX P51813 1/20 0.37
JAK3 P52333 1/20 0.37
ITK Q08881 1/20 0.37
KCNH2 Q12809 1/20 0.37
ERBB4 Q15303 1/20 0.37
SUV39H2 Q9H5I1 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4512140 0.91 CTSK (0.41) BTKCTSKPIM1PIM3PIM2
SCHEMBL5835111 0.91 CTSK (0.41) BTKCTSKPIM1PIM3PIM2
SCHEMBL4506885 0.90 BTK (0.39) BTKCTSKPIM1PIM3PIM2
SCHEMBL4502633 0.90 KDM4D (0.40) BTKCTSKPIM1PIM3PIM2
SCHEMBL4502626 0.90 KDM4D (0.40) BTKCTSKPIM1PIM3PIM2
SCHEMBL4514369 0.89 BTK (0.38) BTKCTSKPIM1PIM3PIM2
SCHEMBL13713227 0.89 TOP1 (0.41) CTSKPIM1PIM3PIM2CKS1B
SCHEMBL4713638 0.88 BTK (0.39) BTKCTSKPIM1PIM3PIM2
SCHEMBL28750386 0.87 BTK (0.39) BTKCTSKPIM1PIM3PIM2
SCHEMBL4524720 0.87 CKS1B (0.40) BTKCTSKPIM1PIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582627-B2 3-Amino-7-[3-(1-aminoethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione; quinolone antibiotics; bactericides; for antibiotic- resistant bacterial infections, ciprofloxacin- resistant ones; inhibiting wild-type and quinolone- resistant mutants of DNA gryase WARNER-LAMBERT COMPANY (US) 2009-09-01 US disclosed
EP-1255739-B1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2008-06-11 EP disclosed
US-20060287308-A1 3-Aminoquinazolin-2,4-dione antibacterial agents ZOETIS WLC LLC 2006-12-21 US disclosed
US-7094780-B1 3-aminoquinazolin-2,4-dione antibacterial agents WARNER LAMBERT COMPANY LLC (US) 2006-08-22 US disclosed
US-20060183762-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS ZOETIS WLC LLC 2006-08-17 US disclosed
EP-1255739-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-11-13 EP disclosed
WO-2001053273-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2001-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183762-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS ABL1, NQO2, CBR3 BTK 2073/4885CTSK 646/4885PIM1 2415/4885
US-20060287308-A1 3-Aminoquinazolin-2,4-dione antibacterial agents ABL1, NQO2, AAAS BTK 2046/4885CTSK 632/4885PIM1 2400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.